Pear Therapeutics – Medical Alley Association
Pear Therapeutics

In the Know: Healthcare News for April 25, 2022

Mayo Clinic Investing $49 Million to Expand Lab Operation in Rochester Why Are There So Many Australian Med-Tech Companies in Minnesota? GrandPad Expands Language Capabilities to Nearly 40 Languages for Senior-Friendly Tablet and Free Companion App Blue Cross and Blue Shield of Minnesota Announces Four Executive Appointments An Interview With New Allina Health Aetna CEO […]

In the Know: Healthcare News for April 4, 2022

UnitedHealth Will Buy Home-Health Care Firm LHC for $5.4 Billion Social Health Care Startup Reema Health Raises $8 Million Miromatrix Moves into New Headquarters Complete with In-House Manufacturing Capabilities TT Electronics Minneapolis Facility Secures FDA Registration Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease Egg Medical Hatches Technology to […]

In the Know: Healthcare News for March 7, 2022

Arden Hills’ Intricon Selling for $241 Million to Private-Equity Group RQM+ Appoints Life Science Executive Margaret Keegan as New CEO Cardiovascular Systems, Inc. Appoints Jeffery W. Chambers, M.D., as Chief Medical Officer LEAH Labs Awarded NIH Phase I SBIR Grant Saluda Medical Announces $125M Equity Financing Led by Redmile Group LLC and New Investors Fidelity […]

For The Record with Rob O’Brien, R.Ph., Vice President, Specialty, Real Endpoints

Rob O’Brien, RE’s VP Specialty, has over 20 years of managed care, PBM, and specialty pharmacy experience. Over the past 2 decades at CVS Health, he has worked closely with payers across all business segments (commercial and government) and drug benefit programs (both pharmacy and medical).  At CVS Health he held a number of leadership […]

In the Know: Healthcare News for December 13, 2021

Bright Health Raising $750 million, Including Cigna investment Med-tech Design Firm Worrell Acquired by Raleigh-Based Veranex Clearlake Capital-backed Provation to be acquired by Fortive CardioMech Performs First In-Person Procedure with Transcatheter Mitral Valve Repair Tech Hennepin Healthcare Hosts ‘Black Men With Stethoscopes Youth Summit’ Itiliti Health Raises $2 million to Streamline Rudimentary Prior Authorization Process […]

Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder

BOSTON, November 22, 2021 – Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its reSET-A™ PDT product candidate designed for the treatment of alcohol use disorder (AUD). reSET-A potentially […]

In the Know: Healthcare News for November 29, 2021

Northern Minnesota’s ANI Pharmaceuticals closes on largest-ever acquisition Medtronic partners with Amazon to bring the PillCam to your door Medtech Firm Cardialen to Kick Off Fifth Clinical Trial Flywheel Partners with Roche and Genentech to Accelerate Development of Personalized Healthcare Solutions MGCD, an Altus Capital Partners Portfolio Company, Announces the Acquisition of Lemon Medical GmbH […]

In the Know: Healthcare News for November 22, 2021

Gov. Tim Walz Promotes Minnesota on Trade Mission to United Kingdom, Finland Department of Defense Medical Team to Support Staff at HCMC and St. Cloud Hospital FDA Clears Medtronic’s PillCam System for Remote Endoscopy Procedures Aurora Pharmaceuticals Launches Scholarship Program at Texas Tech  Hardtech Innovation Center mHUB Announces Portfolio Teams of Premier MedTech Accelerator Cohort […]

Pear Prescription Digital Therapeutics (PDT) Digest

Pear Therapeutics Launches Pear Prescription Digital Therapeutics Digest, Provides Roadmap for Payer Coverage Considerations Pear Therapeutics is the leader in developing and commercializing prescription digital therapeutics (PDTs) to treat serious disease, with three FDA-authorized PDTs Inaugural edition of the Digest explores employer and payer stakeholder knowledge of PDTs as well as current considerations and perceptions […]

Pear Therapeutics Launches Pear Prescription Digital Therapeutics Digest

Boston, October 19, 2021 – Pear Therapeutics, Inc., in collaboration with Avalere Health, an Inovalon company, today launched the Pear Prescription Digital Therapeutics Digest (Pear PDT Digest) at the Academy of Managed Care Pharmacy’s (AMCP) 2021 Nexus conference. The Digest was presented during the Partner Session “Pioneering Prescription Digital Therapeutics to Transform the U.S. Health Care System,” and outlines findings from […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER